Rafarma Pharmaceuticals Inc. (RAFA): I agree !!!! There will always be an exc...

Home > Boards > US Listed > Biotechs > Rafarma Pharmaceuticals Inc. (RAFA)

Followed By	39
Posts	8468
Boards Moderated	5
Alias Born	09/10/2012

IB_

Friday, February 25, 2022 12:13:20 PM

Re: Marty Byrd post# 5795

I agree !!!! There will always be an excuse ........................ until the END,

IB_

SHOW ME THE MONEY OR SHUT UP !!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Follow Board

Keyboard Shortcuts

Report TOS Violation

The Arena Group Appoints Miles Stiverson General Manager of Lifestyle
BED BATH & BEYOND INC. REPORTS FISCAL 2022 FIRST QUARTER RESULTS (ENDING MAY 28th, 2022)
Siemens and NVIDIA to enable industrial metaverse
Aileron Therapeutics Announces Interim Data from Phase 1b Chemoprotection Trial of ALRN-6924 in Patients with p53-Mutated Non-Small Cell Lung Cancer (NSCLC) and Confirms Development Path for ALRN-6924 Focused on p53-Mutated Breast Cancer
General Mills Reports Fourth-Quarter and Full-Year Results for Fiscal 2022 and Provides Fiscal 2023 Outlook
Can-Fite Announces Positive Top-Line Results from Piclidenoson Phase III COMFORT™ Study in Moderate to Severe Psoriasis
VIA optronics AG Reports Unaudited First Quarter 2022 Results
MINISO Group Launches Global Offering
Exicure, Inc. Announces Receipt of Nasdaq Notice of Non-compliance and Implementation of One-for-Thirty Reverse Stock Split
The Gross Law Firm Notifies Shareholders of Amazon.com, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 5, 2022 - (NASDAQ: AMZN)
SEABOURN TAKES DELIVERY OF SEABOURN VENTURE, THE LINE'S FIRST PURPOSE-BUILT ULTRA-LUXURY EXPEDITION SHIP
Galera Announces Results from Phase 1 Stage of GRECO-1 Trial of Rucosopasem with SBRT for NSCLC
Trevi Therapeutics Reports Positive Results from the Ph2b/3 PRISM Trial of Haduvio™ in the Treatment of Prurigo Nodularis
Top Company News of the Day
Beyond Air Shares Climb Nearly 9% After Product Gets FDA Approval
Top Company News of the Day
FTSE 100 Closes Down 0.2% as Uncertainty Persists
EURO STOXX 50 Index Ends 0.99% Lower at 3514.32 -- Data Talk
FTSE 100 Index Ends 0.15% Lower at 7312.32 -- Data Talk
DAX Ends 1.73% Lower at 13003.35 -- Data Talk

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Quotes:

IHub:

Detailed Quote